['schizophrenia']
['paliperidone palmitate']

        Inclusion Criteria:

          -  Has a diagnosis of schizophrenia

          -  Requires acute treatment for symptoms of schizophrenia

          -  Willing and able to be confined to an inpatient study unit for up to 3-4 weeks

          -  Has experienced at least one previous hospitalization for schizophrenia

          -  Has been able to achieve outpatient status for more than 3 months in the past year

          -  Has a body mass index (BMI) between 18.0 and 40.0 kg/m^2

          -  Resides in a stable living situation when not hospitalized

          -  Has an identified reliable caregiver (for example, family member)

          -  Additional criteria may apply

        Exclusion Criteria:

          -  Poses a current suicide risk

          -  Pregnant, planning to become pregnant, or breastfeeding

          -  Initiated first antipsychotic treatment within the past 12 months

          -  Has received a long-acting injectable antipsychotic in the past 3 months

          -  Has participated in a clinical study involving any investigational product within the
             past 3 months, or is currently participating in a clinical study involving an
             investigational product.

          -  A positive urine drug test for drugs of abuse

          -  Additional criteria may apply
      